Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies and services in the cell and gene therapy industry. It operates through the following segments: Octomera and Therapies. The Octomera segment refers to the point-of-care services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
Sector:
Technology Services
Industry:
Packaged Software
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Orgenesis Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Orgenesis Inc market cap is $21,559.00.
What is the 52-week high for Orgenesis Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Orgenesis Inc 52 week high is $2.27 as of May 15, 2026.
What is the 52-week low for Orgenesis Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Orgenesis Inc 52 week low is $0.0001 as of May 15, 2026.
What is Orgenesis Inc stock price today?
Orgenesis Inc stock price today is $0.003.
What was Orgenesis Inc stock price yesterday?
Orgenesis Inc stock price yesterday was $0.0022.
What is the 50-day moving average of Orgenesis Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Orgenesis Inc 50-day moving average is $0.4012.